ZILBRYSQ
DEAD

Serial Number

88850346

Owner

Ra Pharmaceuticals, Inc.

Attorney

Kumiko Ide

Filing Date

Mar 27, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ZILBRYSQ Trademark

Serial Number: 88850346

ZILBRYSQ is a trademark filed by Ra Pharmaceuticals, Inc. on March 27, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Ra Pharmaceuticals, Inc. (10 trademarks)

Cambridge, MA 02140

Entity Type: 03

Trademark Details

Filing Date

March 27, 2020

Registration Date

Not Registered

Published for Opposition

July 28, 2020

Goods & Services

Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents

Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 23, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 23, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 21, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 21, 2023 AITU
SOU EXTENSION 5 FILED
Mar 8, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 8, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 2, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 31, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 31, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 31, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2022 EXRA
SOU EXTENSION 3 GRANTED
Mar 4, 2022 EX3G
SOU EXTENSION 3 FILED
Mar 4, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 4, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 13, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 13, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 13, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 13, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 13, 2021 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 25, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 26, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 26, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 26, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 24, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 22, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 22, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 22, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 22, 2020 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 1, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 1, 2020 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
ASSIGNED TO LIE
Jun 22, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2020 CNEA
ASSIGNED TO EXAMINER
Jun 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2020 NWOS
NEW APPLICATION ENTERED
Mar 31, 2020 NWAP